Evaluation and Management of Hepatocellular Carcinoma

被引：66

作者：

Kulik, Laura M. ^{[1
]}

Chokechanachaisakul, Attasit ^{[1
]}

机构：

[1] NMH, Kovler Organ Transplantat Ctr, Chicago, IL 60611 USA

来源：

CLINICS IN LIVER DISEASE | 2015年 / 19卷 / 01期

关键词：

Hepatocellular carcinoma; Evaluation; Management; Diagnosis; Treatment; DONOR LIVER-TRANSPLANTATION; PORTAL-VEIN EMBOLIZATION; ALPHA-FETOPROTEIN LEVELS; DRUG-ELUTING BEADS; TRANSARTERIAL CHEMOEMBOLIZATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; INCREASED COMPLICATIONS; SURGICAL RESECTION; PROGNOSTIC-FACTORS;

D O I：

10.1016/j.cld.2014.09.002

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The burden of hepatocellular carcinoma is rising and anticipated to escalate and while the best chance for long term cure remains transplantation, however the shortage of available organs remains a limitation. Liver directed therapy can serve the role of bridge/downstaging to transplant or as palliative care. Despite an improved overall survival among patients with HOC, due to advancements in surgical techniques, liver directed and systemic therapy, the 5 year overall survival remains low at 18% high-lightening the need for novel therapies. Surveillance for HOC is key to detect disease at an early stage to increase the chances for a potentially curative option.

引用

页码：23 / 43

页数：21

共 134 条

[1] Complications of Living Donor Hepatic Lobectomy-A Comprehensive Report [J].

Abecassis, M. M. ;

Fisher, R. A. ;

Olthoff, K. M. ;

Freise, C. E. ;

Rodrigo, D. R. ;

Samstein, B. ;

Kam, I. ;

Merion, R. M. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) :1208-1217

[2] Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008 [J].

Altekruse, Sean F. ;

McGlynn, Katherine A. ;

Dickie, Lois A. ;

Kleiner, David E. .

HEPATOLOGY, 2012, 55 (02) :476-482

[3] Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].

Altekruse, Sean F. ;

McGlynn, Katherine A. ;

Reichman, Marsha E. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491

[4] Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis [J].

Andersson, Karin L. ;

Salomon, Joshua A. ;

Goldie, Sue J. ;

Chung, Raymond T. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (12) :1418-1424

[5]

[Anonymous], 2014, NCCN GUID VERS 2 201

[6] NATURAL-HISTORY OF SMALL UNTREATED HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS OF TUMOR-GROWTH RATE AND PATIENT SURVIVAL [J].

BARBARA, L ;

BENZI, G ;

GAIANI, S ;

FUSCONI, F ;

ZIRONI, G ;

SIRINGO, S ;

RIGAMONTI, A ;

BARBARA, C ;

GRIGIONI, W ;

MAZZIOTTI, A ;

BOLONDI, L .

HEPATOLOGY, 1992, 16 (01) :132-137

[7] Resection prior to liver transplantation for hepatocellular carcinoma [J].

Beighiti, J ;

Cortes, A ;

Abdalla, EK ;

Régimbeau, JM ;

Prakash, K ;

Durand, F ;

Sommacale, D ;

Dondero, F ;

Lesurtel, M ;

Sauvanet, A ;

Farges, O ;

Kianmanesh, R .

ANNALS OF SURGERY, 2003, 238 (06) :885-892

[8] Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma [J].

Berry, Kristin ;

Ioannou, George N. .

LIVER TRANSPLANTATION, 2013, 19 (06) :634-645

[9] Intention-to-Treat Analysis of Liver Transplantation for Hepatocellular Carcinoma: Living Versus Deceased Donor Transplantation [J].

Bhangui, Prashant ;

Vibert, Eric ;

Majno, Pietro ;

Salloum, Chady ;

Andreani, Paola ;

Zocrato, Joao ;

Ichai, Philippe ;

Saliba, Faouzi ;

Adam, Rene ;

Castaing, Denis ;

Azoulay, Daniel .

HEPATOLOGY, 2011, 53 (05) :1570-1579

[10] Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis [J].

Bravi, Francesca ;

Bosetti, Cristina ;

Tavani, Alessandra ;

Gallus, Silvano ;

La Vecchia, Carlo .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (11) :1413-+

← 1 2 3 4 5 6 7 8 9 10 →